No abstract

Nanoparticle drug delivery systems are a promising development in cancer therapy for reducing toxicity and drug resistance, whilst improving precision targeting. Several types of nanotechnology are in development, with some receiving market approval and others proving difficult to translate to the bedside. [Formula: see text]

We are very pleased to welcome readers to the 17th volume of Future Oncology. "

The replication crisis has gained traction in the scientific community over the past decade. Basic researchers have shown the reproducibility of key data from the lab is low and there is a clear need to improve lab protocol and technique.

No abstract